Evidence map›Paper›PMID 35032357›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

Prevalence and characteristics of atopic dermatitis among young adult females and males-report from the Swedish population-based study BAMSE.

E K Johansson, A Bergström, I Kull, E Melén, M Jonsson, S Lundin, C-F Wahlgren, N Ballardini

Open access · bronzeAbstract read
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
9.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Sexual Dimorphism in Allergic and Mast Cell-Associated Diseases.Clinical reviews in allergy & immunology · 2026
    Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

E K JohanssonDermatology and Venereology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
A BergströmInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
I KullSachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
E MelénInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
M JonssonInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
S LundinSachs' Children and Youth Hospital, Södersjukhuset, Stockholm, Sweden.
C-F WahlgrenDermatology and Venereology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
N BallardiniInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.ORCID https://orcid.org/0000-0001-6759-346X
Karolinska Institutet · SEKarolinska University Hospital · SEStockholm County Council · SE

Funding

Kronprinsessan Lovisas Research Foundationthe Åke Wiberg foundationthe European Research Council (TRIBAL, grant agreement) 757919the Swedish Asthma and Allergy Association's Research Fundthe Swedish Research Council, Region Stockholm (database management and funding through ALF)
6 · The paper itself

Abstract

backgroundThere is limited knowledge regarding prevalence and characteristics of atopic dermatitis (AD) among young adults in the general population.

objectivesTo study AD among young adults in a Swedish population-based birth cohort, with a particular focus on prevalence, sex differences including risk for AD at different ages, disease course and characteristics of AD at 24 years.

methodsThe BAMSE cohort includes 4089 individuals who have been followed regularly from birth to age 24 years regarding AD and atopic diseases. For this study 3055 individuals who answered questions regarding AD at the 24-year follow-up were included. All were invited to a clinical examination including skin examination, evaluation by William's criteria and collection of blood for analysis of specific IgE, and 2264 individuals chose to participate.

resultsAt 24 years, the 12-month prevalence of AD was 17.8% and more females than males had AD (20.5% vs. 14.8%), P < 0.0001. The point prevalence of ongoing AD at clinical examination was 8.0%. AD severity as assessed by Patient-Oriented Eczema Measure (POEM) did not differ between sexes. The proportion of adult onset of AD was 16.9% (92 of 543), females 17.3% vs. males 16.4%. More females than males with AD at 24 years reported disturbed sleep due to itch (26.1% vs. 15.5%, P < 0.003). IgE sensitization was less common among females with AD than males with AD (61.3% vs. 79.6%, P < 0.0001). In addition, male sex (female sex being the reference) was associated with increased odds for AD the first year of life (OR: 1.31, 95% CI; 1.10-1.56), and decreased odds of AD in adolescence and young adulthood (OR: 0.66, 95% CI; 0.55-0.80).

conclusionsAtopic dermatitis is a common disease among young adults, and even though more females than males have AD at 24 years, adult onset of AD seems to be equally prevalent among both sexes in young adulthood.

Indexed as

Dermatitis, AtopicAdolescentAdultFemaleHumansImmunoglobulin EMalePrevalenceSeverity of Illness IndexSwedenYoung AdultImmunoglobulin E

Identifiers

PMID35032357
PMCPMC9303811
OpenAlexW4206140663

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.